Podcasts about Psilocybin

Limiting the side effects of cancer treatments has been an animating force in the field of oncology for many years, and there's been progress to report on that front, but what if you could target cancer tumors without using radiation or chemotherapy and instead generate heat from inside the tumor to kill cells? That's the quest of our guest today, Dr. Hadiyah-Nicole Green, whose promising research using lasers and nanoparticles to eliminate tumors received Breakthrough Device Designation from the FDA earlier this year. “The laser beam that we're using is low power like a laser pointer, and without activation by the laser, the nanoparticles are harmless. Both are targeted just at the site of the tumor so because we don't use systemic delivery, we avoid all of the systemic side effects,” she explains.Dr. Green is also the founder and president of the Ora Lee Smith Cancer Research Foundation, named for an aunt who raised her and who died of cancer without pursuing curative treatment because of her fear of the side effects. Shortly after, her aunt's husband also died of cancer, opting for treatments that took a heavy toll on his body. “At 22 years old, I saw the horrors of cancer and the horrors of cancer treatment and just felt in my heart that there has to be something better than this,” she tells host Michael Carrese.On this fascinating episode of Raise the Line from Elsevier, we'll explore the science behind Dr. Green's approach, the challenges of raising the millions of dollars needed for human clinical trials, and rethinking the current funding landscape for cancer treatments.Mentioned in this episode:Ora Lee Smith Cancer Research Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Außerdem: Psychedelischer Drogentrip - Gamechanger gegen Depressionen? (10:30) // Mehr spannende Themen wissenschaftlich eingeordnet findet ihr hier: www.quarks.de // Habt ihr Feedback, Anregungen oder Fragen, die wir beantworten sollen? Dann meldet euch über Whatsapp oder Signal unter 0162 344 86 48 oder per Mail an quarksdaily@wdr.de. Von Sebastian Sonntag.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USOne on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingEric Osborne joins George for a wide-ranging, two-hour conversation that moves from personal history into the deepest questions psychedelics raise about science, religion, and healing.Eric traces his own path — a small-town Kentucky upbringing, a spiritual awakening in a garden, a psychedelic retreat that reordered his priorities, and a near-death experience intense enough to leave him sweating blood. From there the conversation opens into the ideas at the center of his book, The Psychedelic Reformation: why "renaissance" is the wrong word for what's happening with these medicines (they never left — they were pushed underground), what the "stay put muscle" is and why it matters more than any technique, the existential weight of real informed consent, and why psilocybin is better understood as a technique to practice than a technology to master.Along the way: gifts from non-material beings, the stolen golden age of psychedelic research, whether mushrooms are medicine, drug, or sacrament, and why science and religion may both be asking the wrong questions about healing and authority.More conversations like this one → truelife.transistor.fmEric's book, The Psychedelic Reformation → ericsosborne.com/the-psychedelic-reformation One on One Video call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_US

Magic mushrooms used to mean a party drug or a bad trip. Today psilocybin is in phase 3 clinical trials, and more women than you would ever guess are quietly microdosing for anxiety, creativity and the mental load of motherhood. In this episode I share why I microdose, how I do it, and everything I wish every woman knew before she tried it. I explain what psilocybin actually is, how much a microdose really is (and what I take), and what happens in your brain: the serotonin 2A receptor, BDNF, neuroplasticity, and why the loop of overthinking goes quiet. Then the energetic side: the crown chakra, the pineal gland, how psilocybin literally changes your brain's frequencies, and why sound has always been part of this medicine. I also get personal. My own microdosing journey before and after postpartum, my Sunday batch cooking ritual, the postpartum anxiety and intrusive thoughts I did not realize I had until I came out of them, and how microdosing helps me stay open to solutions instead of forcing the how. Join me live for The Exhale, my free 90 minute masterclass on peptides, longevity and the nervous system, on September 22 at 2 PM Eastern. Save your seat: https://biohackingbrittany.com/pages/the-exhale If you want me to build a protocol with you, my new one on one longevity program is opening and the waitlist is live. My 1:1 consults are closed, so the waitlist is the only way in, first come first serve: https://biohackingbrittany.com/pages/waitlist WHAT I COVER The podcast update launching next week The Exhale: why you cannot out-peptide a dysregulated nervous system My microdosing story, from talk therapy years ago to postpartum From ancient Mazatec ceremony to phase 3 trials and a possible 2027 launch What psilocybin is, and why it fits your serotonin receptors like a key How much a microdose is: 0.1 to 0.3 grams of dried mushroom, and my sweet spot The toboggan hill analogy, and how microdosing helps you see new solutions The science: serotonin 2A, glutamate, BDNF, psychoplastogens and the default mode network The energetic side: the crown chakra, the pineal gland, alpha waves and 432 and 528 Hz What to expect, and the Fadiman and Stamets protocols Future self work and letting go of the how Moms who microdose, postpartum anxiety, mom brain and Moms on Mushrooms Creativity and the sacral chakra The legal picture in Canada and the US How to start with intention   I TALK ABOUT: 00:00 - The podcast update, and The Exhale masterclass on September 22 07:08 - Why I microdose, and my story before and after postpartum 08:54 - From ancient ceremony to phase 3 trials 11:16 - What psilocybin is, and how much a microdose really is 14:35 - How I microdose on Sunday batch cooking days 15:42 - The toboggan hill: how microdosing helps you see new solutions 19:08 - The science: serotonin 2A, BDNF and the default mode network 21:30 - The energetic side: crown chakra, pineal gland and frequency 24:12 - What to expect, and the Fadiman and Stamets protocols 25:45 - Future self work and letting go of the how 32:07 - Motherhood, postpartum anxiety and creativity 35:21 - The legal picture, and how to start with intention   RESOURCES: The Exhale, my free masterclass, September 22 at 2 PM Eastern: https://biohackingbrittany.com/pages/the-exhale The waitlist for my new one on one longevity program: https://biohackingbrittany.com/pages/waitlist The LongHer Life Longevity Community: https://biohackingbrittany.com/pages/longherlife Schedule35: https://www.schedule35.co/ code: BIOHACKINGBRITTANY Enter the Schedule35 giveaway on my Instagram: https://www.instagram.com/biohackingbrittany/ Moms on Mushrooms, the community for mothers who microdose Dr. Joe Dispenza's work on the pineal gland, meditation and breathwork   CONNECT Instagram: https://www.instagram.com/biohackingbrittany/ Website: https://biohackingbrittany.com This episode is for education only and is not medical advice. Psilocybin is a controlled substance in Canada and federally in the US. Know your local laws and talk to your own provider, especially if you are pregnant, breastfeeding or taking medication. This episode includes a partnership with Schedule35.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from September 5-11, 2026.

"It's really hard to justify a test that has any complications if there isn't any reasonable expectation of benefit," says Dr. Rita Redberg, who has spent her career trying to help fellow clinicians consider the actual value of routine screenings and diagnostic testing in asymptomatic patients. Dr. Redberg -- a cardiologist and professor of medicine at the University of California, San Francisco for more than three decades -- is one of the leading voices advocating for a “high-value care” approach, an uphill fight in a healthcare system that tends to reward action over restraint. Her highest profile effort was launching the instructive “Less is More” series in JAMA Internal Medicine when she served as its editor-in-chief for 14 years. On a related track, her research on the assessment of the safety and effectiveness of medical technology, specifically high-risk cardiovascular devices, has yielded a troubling picture. "We found only 1% of devices enter the market through the FDA's most rigorous approval process. The high-quality evidence to support benefit for these devices that I had assumed was present, wasn't actually there.” Join Raise the Line host Lindsey Smith for an eye-opening exploration of what Dr. Redberg considers to be the overlooked risks and false reassurance of common tests and procedures, and her efforts to put the “do no harm” principle of medicine at the forefront of everyday practice.Mentioned in this episode:UCSF School of MedicineJAMA Internal Medicine's Less is More Series If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

#445 Today's Boondoggle- Getting orders for Operation Green Healing with Army Veteran CJ Cowgill

Sean T. McAllister is an attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines and therapies in the United States.His work includes, among many other clients and matters:Advising doctors, therapists, and licensed professionals on psychedelic assisted therapy (typically ketamine), including defense of licensure in disciplinary proceedingsAssisting clients in getting licensed under Colorado's regulatory psychedelic therapy programAdvising clients on religious exemptions for psychedelic use, including serving as a lawyer for the Church of the Eagle and the Condor and the Church of the Celestial Heart, both of which received formal recognition from the US government to operate ayahuasca churches in the United StatesDrafting Colorado's Natural Medicine Health Act, which legalized four psychedelics in the stateServing as a member of the Denver Psilocybin Mushroom Policy Review PanelServing as General Counsel for the Kura AllianceSean is licensed to practice law in Colorado and California.Episode Highlights▶ Psychedelic law and policy reform in the US▶ The role of indigenous communities and respect for traditional knowledge▶ The evolution of decriminalization and legalization efforts▶ Challenges with patenting and commercialization of plant medicines▶ The importance of indigenous sovereignty and recognition in the psychedelic movement Sean McAllister's Links & Resources▶ https://www.mcallisterlawoffice.com▶ https://www.linkedin.com/in/attyseanmcallister/▶ https://www.instagram.com/mcallister2928/▶ https://www.facebook.com/sean.mcallister.710 Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz

Die AfD siegt bei den Landtagswahlen im ostdeutschen Bundesland deutlich. Die Partei erreicht fast 44 Prozent der Stimmen. Übernimmt die AfD nun also die Regierung in Sachsen-Anhalt? Unsere Deutschlandkorrespondentin Simone Fatzer ordnet ein.  Weitere Themen in dieser Sendung: · Die Weltkarte, wie wir sie kennen, ist verzerrt. Sie stellt die Länder nicht in ihrer tatsächlichen Grösse dar. Die Insel Grönland sieht beispielsweise fast so gross aus wie der ganze afrikanische Kontinent. Das afrikanische Land Togo hat deshalb bei der UNO beantragt, dass langfristig andere Karten als Standard gelten sollen - der Antrag wurde angenommen. Was bringt das? Wir fragen bei Julia Mia Stirnemann nach. Sie ist Professorin für Datenvisualisierung an der Berner Fachhochschule. · Die Berufswahl ist mit etwas vom Schwierigsten im Leben junger Menschen. Vor allem, wenn man sich nicht entscheiden kann. Man studiert Broschüren, geht zu Veranstaltungen und Berufsmessen. So war es zumindest bisher. Im Zeitalter der Digitalisierung werden nun aber auch Kurzvideos und Liveübertragungen wichtiger, so will zumindest ein Verein die Berufswahl erleichtern. Manuel Rentsch von der SRF-Wirtschaftsredaktion hat sich mit dem Thema befasst. · Psilocybin, eine psychoaktive Substanz, die in Magic Mushrooms vorkommt, könnte künftig eine bedeutende Rolle in der Krebsmedizin spielen. Denn der Wirkstoff scheint mehr Potenzial zu haben als bisher bekannt, zeigt eine Studie aus den USA. SRF-Wissenschaftsredaktor Daniel Theis über den neuen Wirkstoff und wie er die Chemotherapie beeinflussen könnte.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of pivotal advances and industry dynamics that are shaping the future of healthcare. The U.S. Food and Drug Administration has recently granted approval to Ionis Pharmaceuticals' Zanvastro, a breakthrough in treating Alexander disease. This condition, a rare neurodegenerative disorder caused by mutations in the glial fibrillary acidic protein gene, has historically posed significant treatment challenges. Zanvastro, an antisense oligonucleotide therapy, is notable for being the first of its kind to target this protein, marking a monumental step in precision medicine. The success of this therapy not only opens new avenues for treating Alexander disease but also highlights the potential of antisense technologies to address other rare genetic disorders. Ionis Pharmaceuticals is poised to further explore this innovative therapeutic approach in other neurodegenerative conditions like Angelman syndrome, reinforcing their leadership in targeting rare genetic diseases at the molecular level. Meanwhile, strategic partnerships continue to transform the metabolic disease treatment landscape. The Menarini Group's partnership with Gan & Lee Pharmaceuticals aims to bring the GLP-1 receptor agonist Bofanglutide to European markets. This collaboration underscores the growing emphasis on GLP-1 therapies for managing type 2 diabetes and obesity. With an investment of $72 million upfront and potential milestone payments reaching $771 million, this partnership illustrates the strategic importance of cross-border collaborations in accelerating drug availability and leveraging regional expertise. In parallel, Argo Biopharma has announced promising phase 2 results for its small interfering RNA therapy targeting plasma prekallikrein in hereditary angioedema. This innovative approach offers a prophylactic treatment option for a disease characterized by severe swelling attacks. By harnessing RNA interference mechanisms, Argo Biopharma joins a broader movement within biotech towards gene-silencing technologies that tackle previously challenging conditions. Further emphasizing innovation, Superluminal Medicines has raised $60 million to advance its AI-discovered MC4R-targeting drug for rare obesity conditions. This initiative highlights the transformative potential of artificial intelligence in drug discovery, enabling rapid identification of therapeutic candidates by analyzing extensive datasets and predicting molecular interactions. The focus on rare forms of obesity reflects a broader trend toward personalized medicine, where treatments are increasingly tailored to specific genetic profiles. Regulatory developments also feature prominently with Liquidia Corporation receiving FDA fast track designation for Yutrepia, an inhaled small molecule aimed at treating systemic sclerosis-related Raynaud's phenomenon. This designation will expedite the development and review process for Yutrepia, facilitating quicker access to this potentially life-enhancing treatment for those suffering from autoimmune complications. However, challenges persist within the industry. The FDA issued a warning letter to Fresenius Medical Care over deficiencies related to complaint handling and contamination inspections for sterile injectable products. This action underscores ongoing concerns regarding compliance with safety standards and highlights the critical need for rigorous quality control mechanisms to ensure patient safety. In exploring new therapeutic modalities, psilocybin has shown promise in managing neuropathic pain through preclinical studies. These findings add to the growing body of evidence supporting psychedelics' potential benefits beyond mental health applications, opening new avenues for pain management therapies that could revolutionize treatment protocols. The competitive landscape in weight management sees significant movement with Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo vying for dominance in oral GLP-1 receptor agonists. As companies race to develop more patient-friendly formulations, these innovations promise to significantly boost adherence and outcomes in obesity management. Lastly, industry trends reveal an evolving marketing landscape where social media collaborations and strategic partnerships are becoming central to engaging patients and advocating medical conditions. For example, Novartis' partnership with a British Olympian aims to enhance multiple sclerosis advocacy by leveraging influential platforms for patient education and empowerment. These developments paint a picture of a dynamic pharmaceutical and biotech sector characterized by scientific innovation, strategic partnerships, regulatory vigilance, and data-driven approaches. As companies continue to navigate these complexities, their ability to leverage cutting-edge technologies and foster global collaborations will be crucial in delivering transformative health solutions. The industry's focus on precision medicine and novel therapeutic modalities promises significant advancements in patient care and disease management in the years ahead. Thank you for joining us at Pharma Daily—your source for the latest news shaping the world of pharmaceuticals and biotechnology.Support the show

After an executive order pushing HHS to speed mental-health treatments, the FDA issued priority vouchers for psilocybin in depression and methylone in PTSD and cleared the first U.S. trial of an ibogaine-related drug. That compound is noribogaine, aimed at alcohol use disorder, and its developers argue it is not hallucinogenic. The scientific question is no longer whether Washington is interested. It is whether cardiac risk, blinding, and psychotherapy can survive a real review.

Brose, Maximilian www.deutschlandfunk.de, Forschung aktuell

Schmude, Magdalena www.deutschlandfunk.de, Forschung aktuell

In this episode of The Observatory, Scott and LaRae share the different aspects of trauma and how we can heal from them. Hear LaRae's traumatic event of losing her mother in a road accident and how it shaped her life differently, Scott's traumatic experience in 1967, and the traumatic event that Scott and LaRae almost died. They also share tips for healing childhood trauma as a family and what LaRae has learned from the Compassionate Inquiry with Dr Gabor Mate.Timestamps[03:22] Events in our childhood that create patterns in our lives[07:25] The feeling of being stuck[09:54] LaRae's traumatic event of losing her mother and how it shaped her life differently [13:12] The different aspects of trauma[21:15] Scott's traumatic experiences in 1967[26:46] The traumatic event that Scott and LaRae almost died[31:30] What LaRae has learned from the Compassionate Inquiry healing model[43:00] The purpose of the message today[47:00] Healing childhood trauma as a familyNotable quotes:“No one experiences childhood the same, even though you are all raised by the same parents and in the same home.” - LaRae Wright [06:09]“The first aspect of trauma occurs when something happens, leading you to interpret it in a way that creates rigidity. This causes you to frame your experience in a programmed manner that constrains you.” - LaRae Wright [13:11]“The second aspect of trauma is when your feelings become overwhelming, causing you to disconnect from them.” - LaRae Wright [13:27]“Life is a defensive game, and we are constantly seeking unconsciously validation of our experience.” - LaRae Wright [31:57]Relevant links:Compassionate Inquiry https://drgabormate.com/compassionate-inquiry/Subscribe to the podcast: Apple PodcastProduced by NC Productions!

For millions of young women and girls, often the first place they turn with questions about their bodies isn't a doctor's office, it's social media which can lead to encountering many misconceptions and outright misinformation. Or, if the right voices show up, it can mean something else entirely. Our guest today, Dr. Charis Chambers, is one of those voices. She's a board-certified OB/GYN with specialty certification in Pediatric & Adolescent Gynecology, and Chief Medical Officer at Clue, a leading period and cycle-tracking app. She's also the founder of The Period Doctor, a platform she launched in 2019 to provide medically accurate reproductive health information and to place more minority physicians in the spaces where patients are already looking for answers. As she tells Raise the Line from Elsevier host Lindsey Smith, Dr. Chambers embraces the role of being a bridge between generations: "I can serve as a medical mediator where I advocate for the child and then educate the parent so that the child's concerns are met." Stay tuned to this important conversation to also learn about: Her new book, The Period and Puberty Parenting Revolution, which tackles many of the same myths she encounters every day in her clinic; Why stubborn myths around periods rarely hold up once you ask where they come from; How she thinks about the responsibility, and limits, of being a trusted medical voice on social media. Mentioned in this episode: Clue The Period Doctor The Period and Puberty Parenting Revolution If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Send us Fan MailAlyssa and Doug talk about how greed and corruption has injured humans and the earth - Alyssa is normalizing conversation about choosing the earth first when making decisions - Doug's energy was like an invitation for Alyssa to fully express herself while being herd and seen - Alyssa experiences a kind of healing after talking with DougMusic: Pure And HolySupport the showInstagram

130. Psilocybin and Menopause: Two Clinicians Reframe Midlife for WomenEpisode SummaryEstrogen regulates the serotonin system, and psilocybin reaches the same receptor. That is where this Salon starts, and it is the most specific version of the psilocybin and menopause conversation I have heard in public.Kelly McGinty, a nurse practitioner, told a full room at Town Hall Seattle that the drop women feel in perimenopause is physiological rather than imagined. I asked whether that means psilocybin replaces estrogen. She said no, and that she would like more research. Her co-author, Dr. Trish Singh, added that research on menopausal women barely exists at any phase of the transition.Two clinicians describe what they see in their patients, then draw a line at the point where the evidence ends. Most people selling a reframe of midlife will not draw that line on a microphone.What sits on the other side of it: anxiety as a knock on the door rather than a malfunction, why women microdose intuitively instead of on a protocol, and the archetypes we inherit about aging women. Kelly's oldest client is 85, and she says the younger generation is watching to see how the older one heals.A woman in perimenopause deserves an explanation for what is happening in her body. Psilocybin is not what delivers that. A provider who knows the full symptom list is.

Psychedelics, hallucinogens, natural medicines, you name it, if it has been, is, or will be in a clinical trial, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!!

Psychedelics, hallucinogens, natural medicines, you name it, if it has been, is, or will be in a clinical trial, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!!

Today's episode features Dr. Jill Wecht who is a Research Health Scientist at the Bronx VA and Devon Colbert, a retired firefighter and Navy Veteran who lives with a cervical spinal cord injury (SCI) and is an advocate/participant in SCI research. A while back, Devon proposed the idea for a clinical trial using psilocybin to Dr. Wecht and her colleague Dr. Noam Harel at the Bronx VA. When we heard that they were moving forward with potentially the first psilocybin trial in spinal cord injury (a safety trial), we reached out to schedule this interview. They are curious about the effect of psilocybin on mental health, but will also be collecting information about its effect on other functions. The hope is that it might have pro-regenerative effects that can warrant further investigation. We talk with them about the trial and the potential that psilocybin might hold as a treatment, both on its own and in combination with other interventions going forward. We learned a lot from the conversation and are excited to share it with you.

In this episode of The Observatory, Jeff Low joins the show to discuss men's mental health and steps toward forging lifelong bonds and reconnecting with your purpose. Jeff founded Bonded Brotherhood, a safe space where men can connect, grow, and find strength in authentic community with the raw power of the outdoors. Hear Jeff's lowest moment and turning point into personal work and healing, his growth since meeting Scott and LaRae in February, and how working on himself has influenced his relationships. You will also learn the power of vulnerability and being in a community in your healing journey, and what Bonded Brotherhood is all about. Timestamps[03:37] Jeff Low's background information and what led him to what he is doing now[07:08] Jeff's biggest regrets in life [10:00] The pressure of growing a business[13:36] Jeff's turning point into personal healing[18:00] The thought of committing suicide in February 2025[23:57] Jeff's growth since meeting Scott and LaRae Wright[27:57] Working on yourself so that you can help others [29:03] How working on himself has influenced Jeff's relationship with his wife[33:00] The power of vulnerability and being in a community [34:32] The story of Bonded Brotherhood[41:45] What does Bonded Brotherhood do?[50:57] The future of Bonded Brotherhood[01:00:20] The importance of curiosity in your healing journey[01:04:00] Learning how to feelNotable quotes:“The gift that you two have of providing a loving, safe space 100% saved my life.” - Jeff Low [18:36]“You are not alone, you are not crazy for feeling and thinking the way you are feeling and thinking, and there is peace, and it comes by putting yourself first.” - Jeff Low [25:29]“You have to be healthy before showing up the best way for others.” - Jeff Low [26:24]“Bonded Brotherhood is all about building connection and support.” - Jeff Low [46:11]Relevant links:Bonded Brotherhood website: https://bondedbrotherhood.com/Instagram: https://www.instagram.com/bonded.brotherhood/Subscribe to the podcast: Apple PodcastProduced by NC Productions!

"I'd already finished my cardiovascular unit. I'd finished my pulmonary unit. I had never heard about this in any of my classes." That was Dr. Joel Bervell's reaction to discovering that a device used every day in hospitals -- the pulse oximeter -- reads less accurately on darker skin tones. He posted a 30-second video about this consequential discrepancy that, to his utter surprise, gained over 500,000 views by the next morning. That video launched Dr. Bervell into orbit as a social media presence and created his identity as The Medical Mythbuster. In just a few years, he's built a following of two million people, earned a Peabody Award and was named to the inaugural Time 100 Creators list, all while finishing his residency.  On this episode of Raise the Line, host Lindsey Smith welcomes Dr. Bervell to explore the roots of this kind of bias and the real world impact of drawing attention to it. “The most impactful biases in medicine exist because no one stops to ask who was included in the original data and who was left out,” Dr. Bervell explains. Stay tuned to also learn about: His YouTube animated series The Doctor is In which helps kids understand how their bodies work, as well as providing medical role models; How to build trust with marginalized communities; His forthcoming book, The Default Body which examines who medicine was actually designed for. Mentioned in this episode:Dr. Bervell on InstagramTikTok ChannelFacebook"The Doctor Is In" Show If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Rick Alexander is a depth-psychological counselor, psychedelic practitioner, and interfaith spiritual care provider currently completing his Ph.D. in Mythology/Depth Psychology and a former Naval Special Operations combat medic. Rick was a Special Operations combat medic until a single psychedelic experience shattered his worldview and sent him back to school to study psychedelic spiritual care. He and Dr. Mike dig into neuroplasticity windows, why “good trip/bad trip” is the wrong question, and what may really be happening in DMT space. Expect to learn how a rough teenage salvia trip and a later psilocybin experience redirected Rick's entire career, what life is really like as a Special Operations Combat Medic supporting SEALs and Green Berets, why military training narrows emotional range and makes civilian re-entry so hard, how integration (not the trip itself) determines whether a psychedelic experience heals or destabilizes you, what the "third wave" of psychedelic science gets right that the DSM's "hallucinogen" label gets wrong, whether neuroplastic windows could help athletes learn skills faster, and what a brutal 5-MeO-DMT experience taught Rick about his own running form and breathing. Connect with Rick: Website Instagram Episodes you'll enjoy next: #47 — Tools to Down-Regulate in Response to Stress (an earlier conversation with Rick Alexander): Listen here #194 — The Pros and Cons of Psychedelic Compounds with Psychedelic Researcher Rebekah Senanayake: Listen here Episode Timestamps: 2:49 – Rick's PhD progress and the psychedelic experience that redirected his career 3:38 – A rough first psychedelic experience with salvia at 18 4:46 – The psilocybin experience that "peeled back" his worldview 7:00 – Life as a Special Operations Combat Medic supporting SEALs and Green Berets 8:23 – How military training narrows emotional range and worldview 10:01 – Why veterans struggle to re-enter civilian life after specialized training 13:34 – The double-edged sword: psychedelics can destabilize as easily as they heal 14:32 – The "third wave" of psychedelic science and the flawed DSM "hallucinogen" label 23:49 – Integration: do you have time to process what comes up? 24:43 – "Psychedelic myth-making" and building a new personal mythology 31:05 – Could neuroplastic windows help athletes learn skills faster? 37:01 – Yogic energy channels (nadis) and psychedelics amplifying subtle perception 39:17 – How a brutal 5-MeO-DMT trip changed Rick's running form and breathing 56:16 – What's really happening in DMT space: Strassman, Gallimore, and "reality switch technologies" 59:43 – Henri Corbin's "psycho-cosmology": consciousness and reality as mirrored levels 1:06:45 – "Functional consequentialism": why you shouldn't dismiss someone else's experience 1:10:46 – Where to find Rick and his counseling and breathwork work Get the Daily Fitness Insider newsletter (free): https://www.miketnelson.com/newsletter

In this episode of The Observatory, Samuel Beautysta joins the show to discuss the ancient art of Zapotec weaving and the living stories carried in each thread. Samuel, a traveling weaver from Oaxaca, Mexico, shares how his curiosity about identity and lineage led him deep into the Benizaa tradition, uncovering the meanings behind patterns, the natural colors drawn from the earth, and the symbols that honor life, death, and ancestry. He reflects on his family's response to his search for knowledge, his experiences traveling and teaching, and how weaving becomes a language that connects cultures and generations. Timestamps[02:31] How Scott and LaRae first met Samuel Bautista[05:36] Samuel's background information on the weaving culture and tradition[13:33] How things unfolded for Samuel after the curiosity of wanting to know who he is[19:02] Samuel's experience in the United Kingdom[20:10] The similarities of Samuel's culture to that of other cultures during his research[25:46] How Samuel's parents reacted to his journey of seeking knowledge about their tradition [29:11] How Samuel discovered the natural colours of weaving[38:43] Samuel's episode on The Reluctant Traveler Show about the Day of the Dead[49:27] Connecting to one another and the Mother Earth[55:34] How Samuel created a community of collaboration and co-creationNotable quotes:“History is always written with an agenda and a hidden power, like governments and institutions. It's up to us to answer questions for ourselves, who we are, our lineage, and our story.” - Samuel Beautysta [11:59]“When we start to discover that we are more similar than we are different, it changes our whole perspective on what our parents taught us.” - LaRae Wright [25:46]“To survive the hottest days of summer, you have to feed your roots, your ancestors, and remember your teachings.” - [43:25]“For us, instead of fearing death, we embraced it and added it to our symbols and rituals.” - Samuel Beautysta [50:38]“All the knowledge is lying dormant within you, just like a seed that is buried in the ground and ready to sprout. ” - Samuel Beautysta [01:07:42]Relevant links:Samuel Beautysta Website: https://dixza.com/Instagram: https://www.instagram.com/sam_dixza/?hl=enFacebook: https://www.facebook.com/dixzarugsSubscribe to the podcast: Apple PodcastsProduced by NC Productions

Despite gains in recent years, Black, Hispanic, and Asian communities are still under-represented in the U.S. nursing workforce. We're going to explore that gap and how to close it on this episode of Raise the Line from Elsevier with Dr. Ernest Grant, Vice Dean for Diversity, Equity, Inclusion and Belonging at the Duke University School of Nursing. "You get a patient who is more compliant when they see someone who looks like them, who is from their culture and who can advocate on their behalf," he tells host Lindsey Smith.  Dr. Grant bases that and other insights on a rich professional background that includes 50 years in nursing, being a leading advocate for his profession and breaking down barriers himself as a male nurse of color and the first man elected president of the American Nurses Association.  In this thoughtful conversation, Dr. Grant reflects on what it took to earn credibility in leadership roles, how he's navigating the political climate on DEI initiatives, and the causes and solutions to the persistent shortage in nursing faculty, among other pressing issues. Tune in for a uniquely-informed look at what it will take to build a stronger, more representative nursing profession. Mentioned in this episode: Duke University School of Nursing American Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

We have been open about our experiences with psychedelics and microdosing and the meaningful role they played in our own journeys into Terrain. But as psychedelics move from the counterculture into clinics, retreats and the mainstream, are we at risk of turning them into another version of the very thing they're supposed to replace: the magic pill?John O'Connor, author of A Short, Strange Trip, joins us for a nuanced look at the psychedelic renaissance through the story of one of its most influential figures, Terence McKenna. John retraced McKenna's journey into the Colombian Amazon, separating some of the history from the mythology and discovering that indigenous relationships with psychoactive plants look very different from the Western stories we've built around them.The conversation becomes deeply personal when John shares his father's unsuccessful attempts to treat decades of alcohol addiction with ketamine and psilocybin-assisted therapy—an experience that forced John to confront his own expectations about these medicines. We explore the danger of placing responsibility for healing onto a substance, why psychedelics may help us rewrite the stories we tell about ourselves without necessarily making those stories true, and the strange contradiction of rejecting the pharmaceutical model only to replace "take this pill" with "take this mushroom."We also get into McKenna's complicated legacy, psychedelic shamanism, ego dissolution and spiritual grandiosity, the therapeutic versus recreational use of psychedelics, indigenous plant traditions, the importance of intention and integration, and why it's possible to recognize the profound potential of these substances without turning them into something they aren't.This isn't a rejection of psychedelics. It's a challenge to hold the promise and the problems at the same time, and to remember that no medicine can do the work of tending our terrain for us.Learn more about John and his work at https://www.johnmoconnor.com/Support Terrain Theory on Patreon! Our member platform gives you access to exclusive content. Check it out: https://www.patreon.com/TerrainTheoryBook a FREE 1:1 call with co-host Ben Hardy to discuss terrain, health, life, anything! Find a day & time here: https://www.terraintheory.net/pages/free-1-1-callTerrain Theory episodes are not to be taken as medical advice. You are your own primary healthcare provider.If you have a Terrain Transformation story you would like to share, email us at ben@terraintheory.net.Learn more at www.terraintheory.netFollow Terrain Theory:Instagram: https://www.instagram.com/terrain_theory/Facebook: https://www.facebook.com/Terrain-TheoryX: https://twitter.com/terraintheory1YouTube: https://www.youtube.com/@terraintheoryMusic by Chris MerendaAfter Party Music by Great Balancing Act

Surveillance camera critics rally in Seattle as company tightens safeguards. Kent officers arrest child rape suspect after ALPR alert during routine patrol. New poll: 75% of Seattleites support CCTV cameras, expansion in wake of multiple shootings. Shootout at Pioneer Square bar prompts questions on offline CCTV camera. Harger: Auburn Police arrested five shoplifters at Fred Meyer and booked them into jail. Here’s why that matters more than you think // Puget Sound VA involved in a federal psychedelic research push. VA launches psilocybin trial for Veterans with treatment-resistant depression // LETTERS

In episode 551 I chat with Andrew who has kindly agreed to share his story with us. We discuss his story, how a bad experience with psilocybin triggered his OCD, trying to control thoughts, medication, acceptance and commitment therapy (ACT), sexual orientation themed OCD, compassion focused therapy (CFT), internal family systems therapy (IFS), working with parts of himself, meditation, and much more. Hope it helps. Show notes: https://theocdstories.com/episode/andrew-551 The podcast is made possible by NOCD. NOCD offers effective, convenient therapy available in the US and outside the US. To find out more about NOCD, their therapy plans and if they currently take your insurance head over to https://go.treatmyocd.com/theocdstories Join many other listeners getting our weekly emails. Never miss a podcast episode or update: https://theocdstories.com/newsletter  

Eric Osborne is the Co-founder and Head Minister of Psanctuary ( https://www.psanctuary.org/ ), a sacred mushroom church based in Louisville, Kentucky. Eric joins me on the podcast today to discuss his pioneering work in the international mushroom indu...

In remembrance of Carol Lynn Pearson, we are honored to reshare this October 2023 conversation and celebrate the extraordinary legacy she leaves behind as a writer, poet, advocate, and courageous voice for love, faith, women, and the LGBTQ community.In this episode of The Observatory, Carol Lynn Pearson joins the show to talk about the doctrine of plural marriage in Mormonism. Hear about how the doctrine of polygamy developed, how polygamy causes irreversible damage, the importance of resonating with love, practical solutions to the problem, and Carol's upcoming books. Timestamps[03:53] Have Carol Lynn's views changed on the doctrine of polygamy.[10:14] Mormonism and polygamy.[18:00] How the doctrine changed over time. [21:11] How polygamy showed up in Carol Lynn's story.[26:54] The damage that this doctrine causes.[44:27] Resonating with love.[51:30] Carol Lynn's favorite passages. [70:41] Solutions to the problem.[74:15] Carol Lynn's diaries. Notable quotes:“It benefits no one.” – Carol Lynn Pearson [04:27]“However we deal with the past, it is the past.” – Carol Lynn Pearson [26:48]“Society must move historically into more and more of a place of light.” – Carol Lynn Pearson [72:15]Relevant Links:Website: carollynnpearson.comSubscribe to the podcast: Apple PodcastProduced by NC Productions

What does it take to compete on the world's biggest stage and then pivot to one of the most demanding training paths in professional life? Today's guest, Samantha "Sammy" Kolowrat, has done both, and she has some fascinating insights into the commonalities of those two worlds on this episode of Raise the Line. “Something that really drew me to medicine is the team atmosphere that's there as you work towards a common goal, and there's this level of intensity that's very reminiscent of the experiences I had as a professional athlete.” Originally from Prague, Kolowrat represented Czechia at six IIHF Women's World Championships and the 2022 Beijing Olympics, and also captained the Division I women's hockey team at the University of Vermont while earning degrees in biology and pharmacology.  As she starts an anesthesiology residency at Vanderbilt University, she credits her athletic career with shaping how she handles pressure, feedback, and teamwork in medicine. "The more I improve, the more knowledge I acquire, the more skills I hone, the better care my patients get," she tells host Lindsey Smith, describing what drew her to a field that rewards the same relentless fine-tuning as elite sports. This engaging conversation also explores: How crippling performance anxiety as a Division I athlete ended up preparing Kolowrat for the operating room; Why she was drawn to anesthesiology's "well-oiled machine" atmosphere; The mentorship gap she's working to close for the next generation of athlete-physicians. Mentioned in this episode: Vanderbilt University Anesthesiology Residency Program If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

"Living life from a different perspective heals the past and also paves the way for the future as well." In this episode, Heather and Eddy Tony explore what it really means to heal, not by becoming someone new, but by integrating the parts of yourself you've spent years trying to outrun. This conversation challenges the idea that transformation comes from a single breakthrough or magic solution, inviting us to consider a gentler process of awareness, compassion, and daily practice. At its heart, this episode is an invitation to trust your own unfolding, soften into the process of becoming, and discover that healing comes from welcoming every part of yourself home, rather than erasing who you've been or clinging to outdated identities. What to listen for: ☑️ How we can change our identity, personality, and how we feel emotionally ☑️ There's no magic bullet for healing, but there is a process to get lasting change ☑️ Why you need to see it, feel it, balance it, and integrate it to step out of old loops   "There is no magic bullet. Where psychedelics are really great at is seeing it, increasing awareness within yourself about old patterns, loops, and behaviors." ☑️ Why everything bubbles up to the surface when it's ready to be transformed ☑️ Navigating the grief of letting go of your former identity and stepping into freedom ☑️ How to commune with the parts you're releasing with deep compassion   "The grieving dissolves and happens on its own because that part also has a home within yourself, within themselves. As opposed to extracting that part, they can integrate and soften back into wholeness." ☑️ Healing doesn't have to be heavy; oftentimes, it's in the small daily decisions ☑️ Looking for the positives inside of challenges, and how that helps us heal ☑️ Coming into full coherence and acceptance, removing the inner war   "It doesn't have to feel so heavy. So leaning into what is happening and seeing the positives that are coming out of it as well. It's about bringing the person into full coherence of what is actually going on." ☑️ Where psilocybin or psychedelics come in and how they create more freedom ☑️ Taking the tips and wisdom of our natural world and applying it to ourselves ☑️ How the intention to release and let go can change your life   Be sure to also listen to episodes 1191, 1203, and 1236 for more! About Eddy Tony: Founder. Author. Guide to over a thousand individuals. The person people turn to when trying harder stops working. Eddy Tony helps his clients release the unconscious pressure patterns that keep life from feeling fulfilling. Known for his calm precision and depth, he guides people back into self-trust, emotional steadiness, and success that finally feels aligned and fully lived. Connect with Eddy: https://www.eddytony.com/ https://www.instagram.com/eddytony https://www.facebook.com/eddytony/  *** For those of you who are ready to stop feeling drained, overextended, and out of alignment… join me inside the Energetic Time Management Accelerator, a focused experience designed to help high-achieving women uncover what's draining them, clarify what truly matters, and create a simple plan that fits their life. We'll pinpoint your biggest time + energy leaks, identify the top areas to focus on for quick momentum, and map out exactly what to let go of so you can reclaim your energy, your time, and your joy. Ready to make your time work for you without adding more to your plate? Join the Energetic Time Management Accelerator: www.heatherchauvin.com/time Explore the top episodes listeners come back to when they're stuck, burned out, or standing at the edge of a big shift: www.heatherchauvin.com/10 Follow Heather on Instagram: www.instagram.com/heatherchauvin_

Jason Grechanik is a master tabaquero trained in the Mamankunawa tradition under curandero Don Ernesto Garcia Torres, with nearly a decade immersed in Amazonian plant medicine traditions. He worked for years at the Temple of the Way of Light, one of the world's most respected Shipibo healing centers. He is the co-founder of the Nicotiana Rustica project — bridging Amazonian sacred tobacco traditions with Celtic tree wisdom — and the host of The Universe Within Podcast, with 180+ episodes and 20,000+ monthly listeners. Jason has guided over 1,000 people through plant medicine work, been featured in DoubleBlind Magazine, and appeared on 30+ podcasts globally. He brings lineage, ethics, and depth to every conversation.  Episode Highlights ▶ Jason's journey from a Santo Daime friend's influence to an unignorable calling into the Peruvian Amazon ▶ Life at the Temple of the Way of Light and the facilitator's role as a bridge between Shipibo and Western worldviews ▶ Tobacco as the "first plant" in Amazonian origin myths, a gateway to the wider plant world ▶ The real difference between tobacco and cigarettes, and the limits of a purely reductionist, molecule-focused view ▶ How tobacco moves through the body in dieta, often surfacing in dreams as movement through dark, blocked places ▶ Why trees are considered the deeper teachers, and what their age and rootedness offer that other plants don't ▶ Tobacco as portal, trees as ongoing teacher: how the two work together in dieta ▶ Ancestral knowledge, the limits of modern assumptions, and building a new maloka, a new earth    Jason Grechanik's Links & Resources ▶ https://www.jasongrechanik.com ▶ https://www.nicotianarustica.org ▶ https://www.theuniversewithin.com ▶ Instagram: https://www.instagram.com/jasongrechanik   Download Beth's free trainings here:  Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business:  https://bethaweinstein.com/grow-your-spiritual-business Integrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business ▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching  ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services ▶ Instagram:  @bethaweinstein  ▶ FB: / bethw.nyc + bethweinsteinbiz  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz

In this powerful episode of Giving Pain Purpose, Lyndsay Soprano sits down with entrepreneur, filmmaker, and psychedelic wellness advocate Zappy Zapolin for a conversation about trauma, chronic pain, and the evolving world of psychedelic-assisted healing.Together, they explore why so many people continue to struggle despite years of traditional treatments and how emerging research is changing the way we think about healing the mind and body. Zappy shares his own transformational journey and offers insight into the unique roles different psychedelic medicines may play in addressing trauma, addiction, depression, anxiety, and chronic pain.Throughout the episode, Lyndsay reflects on her own healing journey and the hope that can emerge when we're willing to explore new possibilities.This conversation is honest, inspiring, and a reminder that healing isn't always about finding another treatment—sometimes it's about discovering an entirely new path forward.Episode Highlights:(00:01) Lyndsay opens up about anxiety, alcohol, and ketamine therapy(02:48) Zappy's vision for psychedelic healing(04:15) Introducing Zappy Zapolin(05:13) Zappy's first psychedelic experience(06:15) From Wall Street to the jungle(08:00) The Reality of Truth and 25 million views(09:30) Meeting God in the jungle(11:00) How ibogaine works and what to expect(14:00) Ayahuasca, psilocybin, and combo explained(20:00) Lois's story from near death to fully healed(26:00) The caterpillar death spiral(32:00) How to start with microdosing(37:00) The CRPS community and why plant medicine matters(38:02) Finding perspective through a mushroom journey(40:21) Don't wait for your doctor(41:04) Where to find Zappy and closing thoughtsFind Zappy Zapolin Online Here:Website: psychedelicconcierge.comInstagram: @zappyzapolinYouTube: @PsychedelicConceirgeLinkedIn: Zappy ZapolinPodcast: Psychedelic Concierge PodcastFind Giving Pain Purpose Online Here:Website: givingpainpurpose.comInstagram: @givingpainpurposeFacebook: The Giving Pain Purpose PodcastLinkedIn: Lyndsay SopranoYouTube: @givingpainpurposeShop: thegivingpainpurposeshop.comSubscribe on YouTube | Merch Shop is OPEN!! | COMING SOON: The Pain Hub - A Women's Healing Community. Subscribe Now!Unfiltered convos. Dark humor. Real healing. This is where pain meets purpose — and you're not doing it alone.++Want to be a guest on Giving Pain Purpose with Lyndsay Soprano? Send her a message on PodMatch, here: Be a Guest on The Show

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's episode delves into the latest innovations and strategic shifts propelling the industry forward. A notable dialogue emerging in psychiatric drug development comes from TLDR Biotech's engagement with Shlomi Raz and Ken Belotsky, co-founders of Palomar Labs. This conversation heralds a transformative shift in psychiatric treatments, moving beyond traditional psychedelics toward novel approaches deeply rooted in human experience. Initially inspired by the therapeutic potential of psychedelics such as psilocybin, early research, notably from Johns Hopkins, sought to establish these compounds within a biopharmaceutical framework. Despite historical evidence supporting their efficacy, challenges persisted in reclassifying these Schedule I substances as viable therapies. Raz and Belotsky, pioneers in this initial psychedelic wave, now lead efforts at Palomar Labs to develop next-generation therapeutics targeting serotonin receptors without the hallucinogenic effects typical of classical psychedelics. This approach seeks to dismantle longstanding industry biases against specific receptor targets known as "anti-targets." A critical concept in their methodology is "neuroplastogens," as popularized by David Olson at UC Davis. These compounds are believed to induce beneficial neuroplastic changes without causing hallucinations. However, Palomar Labs exercises caution, viewing neuroplasticity not as a definitive biomarker for therapeutic efficacy but rather as one of many aspects to consider. Their unconventional "reverse" drug development model begins with anecdotal human experiences and is validated backward through preclinical animal models before advancing to clinical trials. This method relies on overlooked data sources—such as discarded trial reports and traditional medicine use cases—to uncover therapeutic candidates traditionally ignored due to biases against certain receptor targets. For example, they explore therapies for Parkinson's disease bypassing direct dopamine receptor modulation and treatments for Alzheimer's-related aggression avoiding heavily sedative antipsychotics. Palomar Labs' venture studio model emphasizes disciplined capital allocation and an unbiased approach to research outcomes. By prioritizing drug candidates with strong evidence from human experiences, they aim to swiftly advance promising therapies to proof-of-concept stages, readying them for further development by pharmaceutical partners or venture-backed entities. This paradigm shift from target-centric development to a model grounded in empirical human data represents a significant advancement in psychiatric drug discovery. In other industry news, Replimune has successfully navigated regulatory hurdles to secure FDA approval for its melanoma therapy, Tudriqev, following two prior rejections. This achievement underscores the resilience required in drug development and strategic regulatory engagement. The approval highlights the potential of oncolytic virus therapies—Tudriqev employs an innovative approach by using viruses to selectively infect cancer cells while sparing healthy tissue, simultaneously stimulating an immune response. Meanwhile, Eli Lilly continues its dominance in the obesity treatment market with Zepbound, despite new oral competitors. The enduring preference for injectable solutions highlights established efficacy and safety profiles that continue to resonate with healthcare professionals. In China, TransThera has gained regulatory approval for a bile duct cancer treatment, marking a significant step forward for Chinese innovation in oncology. Such advancements not only diversify treatment options but also elevate China's status as a pivotal contributor to global drug development. Challenges persist across the sector, exemplified by Fresenius Kabi's recall of a mislabeled morphine lot due to overdose risks. This incident underscores the vital importance of stringent quality control measures essential for patient safety. The biopharmaceutical landscape also sees Takeda securing FDA approval for its first-in-class orexin receptor agonist targeting narcolepsy—a testament to innovative approaches addressing unmet needs in sleep disorders. Amidst these developments, BioMarin has opted to terminate its $270 million rare disease asset following unsatisfactory Phase 3 results. Such decisions highlight the inherent risks within drug development pipelines and underscore the necessity for strategic flexibility. Leadership changes are shaping corporate trajectories too; BioNTech's appointment of Guido Oelkers as CEO exemplifies this trend. His experience will likely drive strategic realignments crucial for navigating complex industry challenges. Finally, the industry's focus on digital transformation is evident through Bausch + Lomb's partnership with VerilyMe—a collaboration aimed at enhancing dry eye education via digital and AI technologies. These stories collectively embody the dynamic nature of the pharmaceutical and biotech industries—where regulatory achievements, strategic pivots, and technological advancements are continuously redefining therapeutic landscapes and enhancing patient care worldwide. As we continue navigating this rapidly evolving field, staying informed on these developments is crucial for leveraging opportunities and addressing challenges within this innovative sector.Support the show

This episode of the podcast is going to explore what actually happens inside psilocybin assisted therapy, from the first conversation to the last integration session. Specifically, we are going to be walking the entire arc of a legal psilocybin therapy engagement through the lens of naturopathic medicine: preparation, the session itself, integration, the risks, and how to tell whether any of it is right for you. Our guest is Dr. JJ Pursell.   What You'll Learn About:

An 11-year-old boy in rural Zambia once told Dr. Genesis Mwamba that he was about to attend school wearing shoes for the first time in his life. That moment, Dr. Mwamba says, crystallized why he started the Lead Me Back Foundation to provide school supplies and other support to marginalized communities in his native country.   As you'll learn in this inspiring installment in our NextGen Journeys series, Dr. Mwamba started the foundation in 2021while still a medical student because he had experienced the power of education as an “equalizer” in his own life, taking him from humble roots to a career in medicine. He and his colleagues have grown the bootstrapped organization to a point where it now provides hundreds of thousands of people across the country with educational access, climate education and community health clinics. “I've always been drawn to opportunities and initiatives that bring help to humankind,” he tells Raise the Line host Dr. Parsa Mohri. This episode also explores: What building "with" a community rather than "for" it looks like in practice; The storytelling strategy that attracted donors and partners; How his mother's untimely death inspired his commitment to preventive medicine.   Mentioned in this episode: Lead Me Back Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Why does a man with everything going right for him quietly fall apart on the inside? Jeremy Lipkowitz was a PhD student at Duke studying the genetic code that supposedly explains what a human being is. On the outside it looked like a life going exactly to plan. In private he was losing to a compulsion nobody around him knew about, and the more he achieved the worse it got. Eventually he stopped trying to fix himself from the outside, left the program, flew to Myanmar, and ordained as a monk.He has spent the last decade teaching men to do what he did, without religion, dogma, or drugs. His show is Unhooked and his work is at https://unhookedacademy.com/We talk about where shame actually comes from, what happens to you around day four of a silent retreat, and whether moderation is possible with anything engineered to hook you. Late in the episode we get into whether there is anything behind all of this. He says no. I made my case anyway. Neither of us moved, and that exchange might be my favorite part of the conversation.

The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments has established that the protocol is safe, causing no serious adverse events or increases in suicidal thinking or behavior.  In fact, the preliminary clinical results exceeded researchers' expectations. Joining me to discuss psilocybin-assisted therapy and PTSD and the study published in the journal Communications Medicine is Stacey Armstrong , PhD. Dr Armstrong is the Associate Director and Senior Researcher at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University   Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial

This is the first of a two part summer special with Laura Mae Northrup, who was first featured in the original BFTA summer special back in 2022. In this first episode, in an excerpt from her wonderful podcast called Inside Eyes, we hear Laura describe her long and grueling battle with suicidality, which emerged as a result of childhood sexual abuse. In the second episode in two weeks, Laura and Dr. H dive deep into her personal healing journey— what worked, what didn't, and how she was able to finally put her chronic suicidality to rest. Support the showLaura Mae Northruphttps://www.lauramaenorthrup.com/Elemental Psychedelicshttps://www.elementalpsychedelics.com/Explore every episode through themes, domains, formats, and speakers. The BFTA CODEX is a listener-built and curated field guide to the podcast. https://bfta-codex.orgBFTA episode recommendations/Podcast pagehttps://www.craigheacockmd.com/podcast-page/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/Support the show

Psychedelics, hallucinogens, natural medicines, you name it, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!! Pain Guy www.painguy.us

In this episode of The Observatory, Gina Scarpino joins the show to discuss her journey as a psychic medium, the reality of communicating with the other side, and how emerging mediums can confidently develop their gifts. Gina is a Psychic Medium & Spiritual Life Coach who has dedicated her life to uplifting the spirits of others. She shares her first telepathic connection with her grandfather after his passing, how her calling unfolded, and why she feels compelled to support others on a similar path. Timestamps[02:00] Gina's Journey to being a Psychic Medium[04:20] The telepathic connection that Gina had with her dead grandfather[07:57] Gina's why in her Psychic Medium work[09:46] Gina's experience with other mediums in England[13:00] What ‘Psychic' and ‘Medium' means[20:54] Gina's biggest lesson of healing[22:17] How Gina engages with people spiritually[30:11] Gina's experience of teaching 30 students while grieving[34:41] How does medium training look?[38:13] The things that Gina loves doing that keep her energized[44:39] The ‘Charmed to Life Project' Podcast[54:05] Balancing the feminine and masculine[55:40] Gina's revelation about Scott and LaRae WrightNotable quotes:“The term 'medium' means you can communicate with people that have crossed over to the other side.” - Gina Scarpino [13:09]“Where there is a will, there is a way, and you're always guided to where you need to be.” - Gina Scarpino [36:40]“When you bring in the science element to all the spiritual subjects, it gives you something concrete when the spiritual aspect is more fluid.” - Gina Scarpino [46:52]Relevant links:Gina Scarpino Website: https://www.ginajulianscarpino.com/Facebook: https://www.facebook.com/GinaScarpinoPsychicMediumPodcast: https://podcasts.apple.com/us/podcast/the-charmed-life-project/id1829457788Subscribe to the podcast: Apple PodcastProduced by NC Productions

"We have an untapped army of 200,000 PAs that really could step up and drive some change in the healthcare system if we weren't restricted,” says Dr. Jennifer Kolb, capturing her motivation for pushing to update practice regulations for physician associates that date back more than 50 years.  As Chief Medical Officer and Senior Vice President of Clinical Affairs at the American Academy of Physician Associates, Dr. Kolb has been in the middle of the fight at the state and federal level to grant PAs more independence from physicians, full billing rights, and the increased ability to practice across state lines, among other changes.  In this pertinent conversation with Raise the Line host Lindsey Smith, Dr. Kolb explains how these updates could help close huge gaps in access to healthcare, better manage the fight against chronic diseases and improve patient outcomes.   Dr. Kolb also addresses:  Why the name shift from "assistant" to "associate" took her years to fully appreciate; How a 10-year gap in life expectancy across Chicago zip codes shapes her view of health equity; Why PA's shouldn't wait for permission to start making change in their communities. Mentioned in this episode:American Academy of Physician Associates   If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Psychedelic Therapy for Mental Health: Research, Safety, and the Path to FDA Approval: Dr. Will Van Derveer and Keith Kurlander, co-authors of “Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life,” reveal the shift from recreational psychedelics to structured, research-based psychedelic-assisted therapy for conditions like PTSD, depression, and anxiety. Van Derveer describes limitations of conventional psychiatry (citing STAR*D remission rates) and his entry into MDMA-assisted PTSD research after promising results. They contrast controlled clinical protocols—screening, preparation, safe setting, trained facilitation, medical monitoring, and post-session integration—with uncontained recreational use. The discussion covers current policy momentum under Trump and RFK Jr., VA interest for veterans, and key agents: ketamine (including abuse risks and clinic-only Spravato), MDMA (phase 3 but not approved in 2024), psilocybin (phase 3, potential FDA approval), LSD (GAD trials), ibogaine (arrhythmia risk, Mexico clinics), ayahuasca, peyote, and microdosing. They also note commercialization, including Eli Lilly's acquisition of a 5-MeO-DMT nasal spray developer, and emphasize an integrative “all-of-the-above” mental health approach.

Benjamin Forest is a retired military officer turned psychedelic author, speaker, and coach. His transformation began with a life-changing psilocybin journey that lifted him from decades of depression and into a radically new way of living. After his own awakening through plant medicine, he began writing, speaking, and coaching around the subject. In 2025, he published his first book: "Trip of a Lifetime -- The Psychedelic Guide to Healing, Loving, and Living."  Episode Highlights ▶ Military service and discipline ▶ Psychedelic experiences and healing ▶ Systemic challenges in veteran mental health ▶ The role of psychedelics in redefining masculinity ▶ Preparation and integration of psychedelic journeys   Benjamin Forest's Links & Resources ▶ Website: www.benjaminforest.com ▶ Instagram: www.instagram.com/benjamin.forest.bliss ▶Buy his book: https://www.amazon.com/dp/B0FPDPXXXD/   Download Beth's free trainings here:  Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business:  https://bethaweinstein.com/grow-your-spiritual-business Integrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business ▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching  ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services ▶ Instagram:  @bethaweinstein  ▶ FB: / bethw.nyc + bethweinsteinbiz  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz